Tech Company Financing Transactions

XLumena Funding Round

XLumena secured a $25 million Series C funding round on 12/3/2013. Backers included Third Point, Aperture Venture Partners and Ascent Biomedical Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series C

Third Point (Lead Investor) (Jason Hong)

Aperture Venture Partners (Eric Sillman)

Ascent Biomedical Ventures (Avi Kometz)

CLS (Barr Dolan)

Prism VentureWorks (Tony Natale)

Proceeds Purpose
Xlumena will use the Series C proceeds to expand global commercialization efforts for its AXIOS family of devices and continue the process of bringing this innovative platform to the US interventional endoscopy community.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
453 Ravendale Dr. H
Mountain View, CA 94043
Email Address
Xlumena is the leader in the developments of image-guided therapeutic endoscopy products specializing in advanced implants and devices that address multiple markets. Collaborating with top physicians in the field, Xlumena focuses on technology that advances therapy to the next level.
XLumena LinkedIn Company Profile
Social Media
XLumena Company Twitter Account
Company News
XLumena News
XLumena on Facebook
XLumena on YouTube

Management Team

Email & Social
Chief Executive Officer
Greg Patterson
  Greg Patterson LinkedIn Profile  Greg Patterson Twitter Account  Greg Patterson News  Greg Patterson on Facebook
Chief Medical Officer
Kenneth Binmoeller
  Kenneth Binmoeller LinkedIn Profile  Kenneth Binmoeller Twitter Account  Kenneth Binmoeller News  Kenneth Binmoeller on Facebook
VP - Operations
Mark Scratch
  Mark Scratch LinkedIn Profile  Mark Scratch Twitter Account  Mark Scratch News  Mark Scratch on Facebook
VP - R & D
Peter Brown
  Peter Brown LinkedIn Profile  Peter Brown Twitter Account  Peter Brown News  Peter Brown on Facebook
VP - Regulatory Affairs
Jane Beggs
  Jane Beggs LinkedIn Profile  Jane Beggs Twitter Account  Jane Beggs News  Jane Beggs on Facebook



Browse more venture capital transactions:

Prev: 12/3/2013: Blaze Bioscience venture capital transaction
Next: 12/3/2013: Payoff venture capital transaction


Share this article


About Our VC Transactions Data

We document all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary